Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Catheter Cardiovasc Interv. 2019 Mar 1;93(4):707-712. doi: 10.1002/ccd.27914. Epub 2018 Oct 2.
The aim of this study was to determine the prognostic value of contractile reserve (CR) at baseline in patients with low-flow, low-gradient severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR).
Patients with severe AS, left ventricular dysfunction, and low transaortic gradient are at high risk for mortality during surgical aortic valve replacement (SAVR). Furthermore, patients without CR have been shown to have perioperative mortality comparable to that of patients treated medically for severe AS.
We retrospectively analyzed patients who underwent TAVR with a diagnosis of low-gradient severe AS (mean transvalvular aortic gradient < 40 mmHg, LVEF < 50%, and AVA ≤ 1.0 cm or AVAi ≤ 0.6 cm ) and who had a pre-TAVR dobutamine stress echocardiogram (DSE). Patients were stratified by the presence or absence of CR, defined as an increase in stroke volume ≥ 20% during DSE.
From 2008 to 2016, 61 patients with low-gradient severe AS underwent TAVR and had pre-TAVR DSE. CR was present in 31 patients (51%) and absent in 30 (49%). There was no significant difference between the two groups in baseline demographics, medical history, access site, or types of valves. All-cause mortality was similar in both groups at 30 days (13% with CR vs 10% without CR, P = 1.00) and 1 year (29% with CR vs 33% without CR, HR 1.20, 95% CI 0.49-2.96, P = 0.69).
In patients with low-flow, low-gradient severe AS undergoing TAVR, the presence or absence of CR does not predict all-cause mortality at 30 days or 1 year.
本研究旨在确定经导管主动脉瓣置换术(TAVR)治疗低流量、低梯度重度主动脉瓣狭窄(AS)患者基线时收缩储备(CR)的预后价值。
左心室功能障碍和低跨主动脉梯度的重度 AS 患者在接受外科主动脉瓣置换术(SAVR)时死亡率较高。此外,已经证明没有 CR 的患者的围手术期死亡率与接受重度 AS 药物治疗的患者相当。
我们回顾性分析了诊断为低梯度重度 AS(平均跨瓣主动脉梯度 < 40mmHg,LVEF < 50%,AVA ≤ 1.0cm 或 AVAi ≤ 0.6cm)并在 TAVR 前行多巴酚丁胺负荷超声心动图(DSE)的患者。根据是否存在 CR 将患者分层,CR 定义为 DSE 期间每搏量增加 ≥ 20%。
2008 年至 2016 年,61 例低梯度重度 AS 患者接受 TAVR 并在 TAVR 前行 DSE。31 例(51%)存在 CR,30 例(49%)不存在 CR。两组在基线人口统计学、病史、入路或瓣膜类型方面无显著差异。两组在 30 天(CR 组 13%,无 CR 组 10%,P=1.00)和 1 年(CR 组 29%,无 CR 组 33%,HR 1.20,95%CI 0.49-2.96,P=0.69)的全因死亡率相似。
在接受 TAVR 的低流量、低梯度重度 AS 患者中,CR 的有无不能预测 30 天或 1 年的全因死亡率。